Each particular radiotherapy technique employed to treat uveal melanoma has its own set of
benefits and drawbacks. The ocular oncologist can choose amongst these therapies based …

Radioactive iodine-125 (I-125) is the most widely used radioactive sealed source for
interstitial permanent brachytherapy (BT). BT has the exceptional ability to deliver extremely …

Background A large proportion of patients with uveal melanoma develop metastases and
succumb to their disease. Reports on the size of this proportion vary considerably. Methods …

In this study, the long-term patient survival after plaque brachytherapy of uveal melanoma is
examined. All patients treated between 1980 and 1999 at a single institution were included …

A gradual shift in trend from primary enucleation to globe salvaging radiation therapy for the
management of ocular tumors has resulted in the rise of several post-treatment ocular …

Uveal melanoma (UM) is the most prevalent primary intraocular cancer in adult population.
Primary methods for treatment of UM involves surgery Proton Beam Therapy (PBT), Plaque …

Uveal melanoma (UM) is an orphan disease with a mortality of 80% within one year upon
the development of metastatic disease. UM does hardly respond to chemotherapy and …

Simple Summary Uveal melanoma is the most common intraocular cancer. The current eye-
sparing treatment options include mostly plaque brachytherapy. However, the effectiveness …

Background In contrast to most other cancers, uveal melanoma (UM) is characterized by an
absence of major improvements in patient survival during the last several decades. In this …

This study aimed to identify prognostic factors in patients with metastatic uveal melanoma
(UM) that were associated with long-term survival in a real-world setting. A total of 94 …